Jun 25, 2019 06:00AM
Oct 29, 2018 06:30AM
Aug 7, 2018 06:30AM
Jun 11, 2018 09:16AM
May 3, 2018 06:30AM
Mar 15, 2018 06:30AM
Feb 20, 2018 06:54AM Vical (VICL) Commences Phase 2 Trial of VL-2397 Antifungal for Invasive Aspergillosis
Feb 20, 2018 06:00AM
Feb 1, 2018 06:30AM
Jan 30, 2018 04:19PM
Jan 30, 2018 04:15PM
Jan 29, 2018 10:17AM
Oct 23, 2017 06:30AM
Oct 2, 2017 04:17PM Vical's (VICL) Antifungal VL-2397 is Eligible for LUI Approval by FDA Based on Single Phase 2 Efficacy Trial
Oct 2, 2017 04:15PM
Sep 28, 2017 06:00AM
Aug 8, 2017 06:30AM
Jun 5, 2017 06:32AM
Jun 5, 2017 06:30AM
May 23, 2017 06:30AM
May 15, 2017 06:30AM Vical Reports First Quarter 2017 Financial Results
May 2, 2017 04:36PM
Apr 19, 2017 06:31AM
Apr 19, 2017 06:30AM
Mar 9, 2017 06:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All